IMMUNIC, INC. (IMUX) › Capital ExpendituresIMMUNIC, INC. (IMUX) — Capital ExpendituresAnnual figures by fiscal year, from SEC filings.2012: $261.0K2013: $1.48M2014: $1.41M2015: $2.34M2016: $556.0K2017: $685.0K2018: $32.0K2019: $55.0K2020: $146.0K2021: $67.0K2022: $112.0K2023: $334.0K2024: $264.0K2025: $161.0K$161.0K2012Capital Expenditures (USD)2025Fiscal YearCapital ExpendituresChange YoY2025$161.0K-39.0%2024$264.0K-21.0%2023$334.0K+198.2%2022$112.0K+67.2%2021$67.0K-54.1%2020$146.0K+165.5%2019$55.0K+71.9%2018$32.0K-95.3%2017$685.0K+23.2%2016$556.0K-76.2%2015$2.34M+66.1%2014$1.41M-5.1%2013$1.48M+468.6%2012$261.0K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowShares OutstandingDividends Per Share